Anti-Adalimumab Antibodies in Patients with Inflammatory Ocular Diseases: Incidence and Clinical Outcomes. Liberman P, Yu SE, Mendez IJ, Ramos EM, et al. Am J Ophthalmol 2026 Jun 9:S0002-9394(26)00305.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liberman P, Yu SE, Mendez IJ, Ramos EM, et al. Anti-Adalimumab Antibodies in Patients with Inflammatory Ocular Diseases: Incidence and Clinical Outcomes. Am J Ophthalmol 2026 Jun 9:S0002-9394(26)00305.
PMID: 42263800